The combination action of IL-2 and IL-4 could also inhibit adhesive and chemotactic functions of CCR9 on these cells.
功能检测发现IL 2和IL 4联合作用亦可相应抑制这些细胞上CCR9的黏附功能和趋化功能。
Compounds are provided that act as potent antagonists of the CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR9.
本发明提供用作CCR9受体的有效拮抗剂的化合物，动物治疗显示这些化合物用于治疗炎症，一种CCR9的标志疾病。
Compounds are provided that act as potent antagonists of the CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR9.
本发明提供用作CCR9受体的有效拮抗剂的化合物，动物治疗显示这些化合物用于治疗炎症，一种CCR9的标志疾病。
应用推荐